References
- Chau K, Hennessy A, Makris A. 2017. Placental growth factor and pre-eclampsia. Journal of Human Hypertension 31:782–786.
- Duckworth S, Chappell LC, Seed PT, Mackillop L, Shennan AH, Hunter R. 2016. Placental growth factor (PLGF) in women with suspected pre-eclampsia prior to 35 weeks' gestation: a budget impact analysis. PLOS One 11:e0164276.
- Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, et al. 2019. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stopped-wedge cluster-randomised controlled trial. Lancet 393:1807–1818.
- Duley L, Meher S, Hunter KE, Seidler A, Askie LM. 2019. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 33. Art. No: CD004659.
- Giannakou K, Evangelou E, Papatheodorou SI. 2018. Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet Gynecol 51:720–730.
- Karin L, Thilganathan B, Papageorghiou A. 2011. Early prediction and prevention of pre-eclampsia. Best Practice & Research Clinical Obstetrics & Gynaecology 25:343–354.
- Marina S, Marina D, Marina F, Fosas N, Galiana N, Jové I. 2010. Sharing motherhood: biological lesbian co-mothers, a new IVF indication. Human Reproduction 25:938–941.
- National Institute for Health and Care Excellence (NICE). 2019. Hypertension in pregnancy: diagnosis and management. NG133. London: National Institute for Health and Care Excellence.
- Roberge S, Bujold E, Nicolaides KH. 2018. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. American Journal of Obstetrics and Gynecology 218:287–293.
- Schwarze JE, Borda P, Vásquez P, Ortega C, Villa Sonia Crosby JB, Pommer J. 2018. Is the risk of preeclampsia higher in donor oocyte pregnancies? A systematic review and meta-analysis. JBRA Assisted Reproduction 22:15–19.